1-1 of 1
Jorg Cammenga, MD, Ph.D.
Close
Sort by
Journal Articles

Smad4 as a Therapeutic Target in Nup98-HoxA9-Induced Leukemia.

Ronan Quere, Ph.D., Goran Karlsson, Ph.D., Silja Andradottir, Marianne Rissler, Karin Olsson, Falk Hertwig, Kristian Reckzeh, MSc, Jorg Cammenga, MD, Ph.D., Stefan Karlsson, MD, Ph.D.
Journal: Blood
Blood (2008) 112 (11): 1799.
https://doi.org/10.1182/blood.V112.11.1799.1799
Published: 2008